We are looking for children 2–17 years of age to join a CD research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or moderate to severe IBD (including associated symptoms such as stomach pain, mouth sores, constant need to poop, frequent fevers and/or anemia), consider one of our research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
